Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake
暂无分享,去创建一个
B. Fei | C. Moreno | D. Schuster | A. Osunkoya | V. Master | P. Nieh | J. Nye | M. Goodman | Zhengjia Chen | Weiping Yu | R. Halkar | Zhibo Wang | B. Savir-Baruch | Rianot Amzat | Pooneh Taleghani | Tim Fox
[1] D. Schuster,et al. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents , 2012, Medicinal research reviews.
[2] B. Fei,et al. Increased expression of Ki-67 correlates with synthetic amino acid PET radiotracer uptake in prostate cancer , 2012 .
[3] P. Choyke,et al. 11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation , 2012, The Journal of Nuclear Medicine.
[4] S Larry Goldenberg,et al. Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours , 2012, BJU international.
[5] F. Bowman,et al. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. , 2011, Radiology.
[6] N. Shikano,et al. Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer , 2011, Journal of Nuclear Medicine.
[7] P. Choyke,et al. GE-148 (18F) injection PET/CT imaging and multiparametric MRI for detection of localized prostate cancer using customized MRI-based specimen molds , 2011 .
[8] H. Jadvar. Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline , 2011, The Journal of Nuclear Medicine.
[9] Hao Hong,et al. Positron emission tomography imaging of prostate cancer , 2010, Amino Acids.
[10] Ziding Feng,et al. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. , 2009, The Journal of urology.
[11] D. Schuster,et al. Case Study of Anti-1-Amino-3-F-18 Fluorocyclobutane-1-Carboxylic Acid (Anti-[F-18] FACBC) to Guide Prostate Cancer Radiotherapy Target Design , 2009, Clinical nuclear medicine.
[12] A. Alavi,et al. Role of Imaging in Prostate Cancer. , 2009, PET clinics.
[13] Y. Kanai,et al. L‐type amino‐acid transporter 1 as a novel biomarker for high‐grade malignancy in prostate cancer , 2009, Pathology international.
[14] P. Kao,et al. Diffuse FDG uptake in acute prostatitis. , 2008, Clinical nuclear medicine.
[15] S. Kohlfuerst,et al. The value of 18F-Choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[16] Sven Perner,et al. Imaging prostate cancer with 11C-choline PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] R. Yancik,et al. Population aging and cancer: a cross-national concern. , 2005, Cancer journal.
[18] Mario Marengo,et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Andreas Scorilas,et al. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. , 2005, In vivo.
[20] B. Fuchs,et al. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? , 2005, Seminars in cancer biology.
[21] Takako Yamaguchi,et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[22] J. Pruim,et al. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Heiko Schöder,et al. Positron emission tomography for prostate, bladder, and renal cancer. , 2004, Seminars in nuclear medicine.
[24] P. Scardino,et al. Expression of neutral amino acid transporter ASCT2 in human prostate. , 2003, Anticancer research.
[25] M. Goodman,et al. Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[26] David R. Haynor,et al. PET-CT image registration in the chest using free-form deformations , 2003, IEEE Transactions on Medical Imaging.
[27] T. Shiga,et al. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[28] M. Frydenberg,et al. Investigations with FDG-PET Scanning in Prostate Cancer Show Limited Value for Clinical Practice , 2002, Acta oncologica.
[29] A W Partin,et al. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. , 2000, Urology.
[30] M. Bergström,et al. Positron emission tomography (PET) with 11C-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma. , 1997, Nuclear medicine and biology.
[31] D. Schuster,et al. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells. , 2012, Nuclear medicine and biology.
[32] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[33] A. D'Amico,et al. NCCN clinical practice guidelines in oncology: prostate cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[34] H. Jadvar. Prostate Cancer : PET with 18 F-FDG , 18 For 11 C-Acetate , and 18 For 11 C-Choline , 2010 .
[35] J. Votaw,et al. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] F DuBois Bowman,et al. Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] Z. Lengyel,et al. Detection of prostate cancer with 11C-methionine positron emission tomography. , 2005, The Journal of urology.
[38] S. Bigler,et al. Prostate cancer tumor location as predicted by digital rectal examination transferred to ultrasound and ultrasound‐guided prostate needle biopsy , 1992, Journal of cellular biochemistry. Supplement.
[39] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.